Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€7.30

€7.30

5.800%
0.4
5.800%
€10.11
 
30.04.24 / Stuttgart Stock Exchange WKN: 607917 / Symbol: MDRX / Name: Allscripts / Stock / Healthcare Equipment & Supplies / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Allscripts Healthcare Stock

A very strong showing by Allscripts Healthcare today, with an increase of €0.40 (5.800%) compared to yesterday's price.
The community is currently still undecided about Allscripts Healthcare with 1 Buy predictions and 0 Sell predictions.
With a target price of 10 € there is a positive potential of 36.99% for Allscripts Healthcare compared to the current price of 7.3 €.

Pros and Cons of Allscripts Healthcare in the next few years

Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
B****
Cons
?
S********** s********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Allscripts Healthcare vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Allscripts Healthcare 5.800% 0.000% 6.154% -37.273% -25.405% -45.238% -20.935%
MicroVision Inc -2.870% 4.570% -18.865% -23.793% -45.642% -89.161% 53.557%
Fonar Corp. New -0.670% -0.662% -24.242% 7.914% -15.254% 5.634% -15.302%
Fluidigm Corp. 0.890% -4.274% -8.197% 48.344% 8.738% -45.492% -

Comments

Prediction Buy
Perf. (%) -24.39%
Target price 10.113
Change
Ends at 19.01.25

Veradigm Inc. (NASDAQ: MDRX) had its price target lowered by analysts at Royal Bank of Canada from $22.00 to $11.00. They now have an "outperform" rating on the stock.
Ratings data for MDRX provided by MarketBeat
Show more